After big gains, Cystic Fibrosis Foundation bankrolls research toward cures — and drugs for those left out
Last week, the cystic fibrosis community celebrated the approval of a new drug from Vertex Pharmaceuticals, a decision that offers the large majority of patients access to cutting-edge treatments.
Those treatments, however, don’t cover patients with certain rare mutations. And they are not cures for anyone.
